Log in to search using one of your social media accounts:

7 medtech stories we missed this week: May 26, 2017
[Image from unsplash.com]From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The licensing agreement is going to help with the development, manufacture and commercialization of an investigation preclinical antibody candidate that targets the protein tau. Merck will have exclusive worldwide rights to develop, manufa...
Source: Mass Device - May 26, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Patient Monitoring Pharma Pharmaceuticals Research & Development Surgical EarlySense Janssen Pharmaceuticals Life Spine Inc. Masimo MedTech Merck Midmark Procept BioRobotics Shenzhen Lachesis Mhealth Teijin Pharma Thermi Source Type: news

Study: Vitamin D during pregnancy may prevent childhood asthma
Researchers have found that taking vitamin D supplements in pregnancy may help protect against asthma and respiratory infections in childhood. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 26, 2017 Category: Consumer Health News Source Type: news

Morning Break: More Docs on the Way; What Is Botulism? Lap Band Demise
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 26, 2017 Category: Respiratory Medicine Source Type: news

Vitamin D in pregnancy may help prevent childhood asthma
(King's College London) A new study published today in the Journal of Allergy and Clinical Immunology has found that taking Vitamin D supplements in pregnancy can positively modify the immune system of the newborn baby, which could help to protect against asthma and respiratory infections, a known risk factor for developing asthma in childhood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 26, 2017 Category: International Medicine & Public Health Source Type: news

Remission Up for Mepolizumab in Eosinophilic Granulomatosis
Significantly more weeks of accrued remission for mepolizumab treatment versus placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 26, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Allergy, Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news

American Thoracic Society, May 19 - 24
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 26, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Critical Care, Pulmonology, Conference, Source Type: news

ATS: Mortality Down for Patients Hospitalized With COPD in U.S.
Annual number of patients who died from COPD while in the hospital decreased 62 percent from 2005 - 2014 (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 25, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pulmonology, Conference News, Source Type: news

Study: Radiation may boost immunotherapy in mesothelioma treatment
Doctors in Pennsylvania reported this week that combining immunotherapy drugs with radiotherapy could help to more efficiently treat malignant pleural mesothelioma. The analysis from the University of Pennsylvania looked at studies that combined immunotherapy drugs like Merck‘s (NYSE:MRK) Keytruda with radiation therapy. The team concluded that radiotherapy may boost the cancer-killing effects of immunotherapies. Get the full story at our sister site, Drug Delivery Business News. The post Study: Radiation may boost immunotherapy in mesothelioma treatment appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 25, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development Respiratory Merck Source Type: news

Path to Empathy Deemed As Vital As Being Empathetic
Conclusion could be especially useful in context of medical professions, researcher says (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 25, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

5 Ways We Can Begin Taking Preventative Measures Today To Improve Brain Fitness
This study was one of the catalysts for other researchers to begin exploring just how malleable the brain truly is, and how brain performance can be improved through deliberate practice. Combine these two categories of brain health—diagnosable diseases and “brain fitness”—and suddenly a new conversation has risen: can neuroplasticity-based brain training and related research-to-practice innovation actually impact mental health, help improve people’s lives, and finally, have a significant impact on the associated economic issues. BrainFutures thinks so. BrainFutures 2017, a conference set for ...
Source: Healthy Living - The Huffington Post - May 25, 2017 Category: Consumer Health News Source Type: news

NCPF training course - Identification of Pathogenic Fungi
Each July the Mycology Reference Laboratory, which houses the NCPF, runs a course on the identification of pathogenic fungi. The four day course is designed for beginners and those with some experience in the identification of medically important fungi. The isolates delegates will be given to examine include a wide range of moulds and yeasts, with particular emphasis on dermatophytes and other organisms encountered in hospital microbiology laboratories. It includes a number of species featured in external quality assessment schemes.Courses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 25, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

National Collection of Pathogenic Fungi Launches Newsletter
News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 25, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Death Rate Drops for Americans Hospitalized With COPD
Title: Death Rate Drops for Americans Hospitalized With COPDCategory: Health NewsCreated: 5/24/2017 12:00:00 AMLast Editorial Review: 5/25/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 25, 2017 Category: Respiratory Medicine Source Type: news

Death Rate Drops for Americans Hospitalized With COPD
Better technology may help patients survive complications of the respiratory disease, researchers say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 24, 2017 Category: Respiratory Medicine Tags: Nursing, Pulmonology, Preventive Medicine, News, Source Type: news

Pandemic and Epidemic-Prone Diseases
World Health Organization. 02/2017 This introductory level online course aims to equip frontline responders with the latest know-how to manage outbreaks of known and emerging epidemic-prone diseases in the 21st century. It focuses on 13 infectious hazards, offering the most relevant scientific, technical, and operational knowledge through video presentations and self-tests. Diseases discussed include Ebola, Middle East respiratory syndrome (MERS), pandemic influenza, yellow fever, and Zika. (Video or Multimedia) Site requires free registration. (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 24, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

10th European Meeting on Molecular Diagnostics
Date: Wednesday, May 24, 2017Year: 2017Location: Grand hotel Huis ter Duin in Noordwijk aan Zee, The Netherlands. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

1st International Eurasian Mycology Congress
Date: Wednesday, May 24, 2017Year: 2017Location: Manisa Celal Bayar University, Anemon Hotel in Manisa, Turkey (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ERROR: ISHAM Newsletter
For those who received a copy of the ISHAM newsletter on or around 19th May 2017 (i.e. end of last week) ISHAM have discovered that one of the conferences featured is not one they wish  to associate with as members have highlighted that it falls below a standard they would expect.The conference in question is  The Annual Congress on Fungal Infections, Diseases& Treatment is planned November 16-17, 2017 in Atlanta, Georgia, U.S.A., organized by Pulsus Group Inc.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

eANOFEL Medical Mycology Educational Website Opens
The French College of Parasitologists and Medical Mycologists (ANOFEL) has launched an educational website called " eANOFEL " . Available in French/English and completely free after registration, this website is a database consisting of more than 1800 pictures and video clips covering all fields of Medical Mycology (and Parasitology). New pics/videos have just been added. Contact:  Florent Morio orDominique Chabasse.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ImResFun2017: Registration Now Open
Date: Wednesday, May 24, 2017Year: 2017Location: Innsbruck, Austria (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington. The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in pote...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news

Planning for the 20th ISHAM Congress is proceeding
The main traits of the program of 20th ISHAM Congress in Amsterdam are nearing completion and will soon appear on the website. Abstract submission will be possible from 1 August onwards. Note that there are several pre- and post-congress activities: workshops on dermatophytes, black yeasts and chromoblastomycosis, veterinary mycology, a course on histopathology, and more to come. If your organization wishes to have a meeting or otherwise, pleasecontact the organization.Updates (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

ATS Roundup: Emulate models viral infection in “asthma-on-a-chip”
Emulate‘s small airway-lung chip could help researchers study viral-induced exacerbations of asthma, according to data presented this week at the American Thoracic Society’s annual meeting. The studies were conducted as part of the company’s partnership with (NYSE:MRK). The collaborative project was designed to enable development of new anti-inflammatory treatments for patients with asthma, according to Emulate. Get the full story at our sister site, Drug Delivery Business News.   The post ATS Roundup: Emulate models viral infection in “asthma-on-a-chip” appeared first on MassDevice....
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Emulate Inc Merck Source Type: news

eANOFEL images
The eANOFEL website is a library containing more than 1800 images (600 medical mycology (May 2017)) and some video clips covering all themes of Parasitology and Medical Mycology. This educational tool is dedicated both to teachers who wish to illustrate their presentations and students to complete their training effectively. It provides images on the morphology of parasites (including some in motion) and on major fungal species of medical interest, on their epidemiology and the diseases they cause. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Research fellows (early career research fellowship)
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Hookahs vs. Cigarettes (Addiction and Health Dangers)
Title: Hookahs vs. Cigarettes (Addiction and Health Dangers)Category: Diseases and ConditionsCreated: 5/24/2017 12:00:00 AMLast Editorial Review: 5/24/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 24, 2017 Category: Respiratory Medicine Source Type: news

Nearly 500 supporters joined ATS rally on Capitol Hill: Lab coats for lungs
(American Thoracic Society) In an ATS 2017 International Conference first, respiratory health professionals and patients joined other conference attendees at a rally near the Capitol on Tuesday, May 23 to voice their concerns about recent policies that threaten to undermine many of the ATS's advocacy priorities including: research funding, tobacco regulation, affordable health care, and clean air. Also participating in the rally was US senators Edward Markey (D-MA) and Tom Carper (D-DE). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2017 Category: International Medicine & Public Health Source Type: news

8 Habits That Make Millennials Stressed, Anxious And Unproductive
A version of this article was originally published on Forbes. Sign up for Caroline’s newsletter to get her writing sent straight to your inbox. According to the American Psychological Association (APA), millennials experience more stress and are less able to manage it than any other generation. More than half of us admit to having lain awake at night during the past month from stress. Not surprisingly, millennials are also more anxious than older Americans. The APA reports that 12 percent of millennials have a diagnosed anxiety disorder—almost twice the percentage of Boomers. On a non-clinical scale, a BD...
Source: Healthy Living - The Huffington Post - May 24, 2017 Category: Consumer Health News Source Type: news

ATS: Lower ARDS Mortality at High - Volume Intensive Care Units
Lower ICU mortality, hospital length of stay for acute respiratory distress syndrome at high - volume ICUs (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 24, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Critical Care, Nursing, Pulmonology, Conference News, Source Type: news

Treatment of COPD Exacerbations Varies by Respiratory Symptom (CME/CE)
(MedPage Today) -- Steroids much more likely for patients with dyspnea, researchers find (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 23, 2017 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 23, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Philips picks up airway clearance device dev RespirTech Royal Philips said today it inked a deal to acquire airway clearance solution developer RespirTech for an undisclosed amount. St. Paul, Minn.-based RespirTech was founded ...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Filtered Cigarettes May Up Rates of Lung Adenocarcinoma
Design of cigarette filters with ventilation implicated in rising rates (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pulmonology, Journal, Source Type: news

VitalConnect closes $33m Series C round
Wearable biometric diagnostic patch company VitalConnect said today it closed a $33 million Series C preferred stock financing round. The funding round was led by newly invested MVM Life Science Partners and Baxter Ventures, the San Jose, Calif.-based company said. As part of the round, MVM founder Dr. Stephen Reeders will join the company’s board of directors. “MVM has been looking for some time for a wireless technology that can deliver better care for patients and a high return on investment for providers, across a range of care environments. We have found it in VitalConnect,” MVM founde...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Vital Connect Source Type: news

ATS: Sleep Apnea, Insomnia in Blacks Often Go Undiagnosed
High prevalence of undiagnosed sleep disorders seen in study population (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Nursing, ENT, Pulmonology, Conference News, Source Type: news

ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news

Pot Use May Boost Respiratory Burden in Middle Age (CME/CE)
(MedPage Today) -- Exacerbation still a problem even without concurrent tobacco use (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2017 Category: Allergy & Immunology Source Type: news

Philips picks up airway clearance device dev RespirTech
Royal Philips (NYSE:PHG) said today it inked a deal to acquire airway clearance solution developer RespirTech for an undisclosed amount. St. Paul, Minn.-based RespirTech was founded in 2004 and has approximately 210 employees. The company produces airway clearance devices for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease and cystic fibrosis. Philips said that the addition of RespirTech’s portfolio will allow Philips to “accelerate its growth in respiratory care,” specifically for COPD patients with bronchiectasis. The acquired portfolio includes a clinica...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Respiratory royal-philips Source Type: news

Novartis ’ Ultibro Breezhaler tops corticosteroid for COPD in head-to-head study
Novartis (NYSE:NVS) said today that a new analysis of its head-to-head Flame trial showed that inhaled corticosteroids may not be necessary in some chronic obstructive pulmonary disease patients with high blood eosiophil counts. The data demonstrated that the company’s Ultibro Breezhaler provided better or similar benefits compared to Seretide, an inhaled corticosteroid, in COPD patients regardless of eosiophil count. These results contrast with previous work suggesting better outcomes with inhaled corticosteroids for patients with high eosinophil counts. Get the full story at our sister site, Drug Delivery Business ...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Novartis Source Type: news

Philips-Sponsored Clinical Study Demonstrates Significant Breakthrough for COPD Treatment
Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation. (Source: eHealth News EU)
Source: eHealth News EU - May 23, 2017 Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news

Could 'Safer' Filtered Cigarettes Be More Deadly?
Title: Could 'Safer' Filtered Cigarettes Be More Deadly?Category: Health NewsCreated: 5/22/2017 12:00:00 AMLast Editorial Review: 5/23/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - May 23, 2017 Category: Respiratory Medicine Source Type: news

ATS: First Abx Rx Doesn ’ t Work for ~ 25 % of Pneumonia Cases
One in four adult patients do not respond to initial prescription of antibiotic treatment (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Conference News, Source Type: news

Poverty Affects Severity of Organ Damage Due to Lupus
And, pregnancy complications higher among non - white patients with lupus (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Nephrology, Neurology, Nursing, Pathology, Pulmonology, Rheumatology, Journal, Source Type: news

FDA labels Philips Respironics V60 ventilator recall as Class I
The FDA today labeled a recall of Royal Philips (NYSE:PHG) Respironics‘ V60 ventilators as Class I. Class I recall designations, the agency’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The Respironics V60 non-invasive ventilator is designed to provide continuous or intermittent breathing support to pediatric patients weighing at least 44 lbs or adult patients, according to the recall notice. The company is recalling the device over issues with pins within the internal cable that conne...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Respiratory Respironics royal-philips Source Type: news

Holliston biotech faces possible delisting, but CEO remains confident
Biostage, a Holliston-based biotech developing organ implants to treat cancers in the respiratory tract, said Monday it faces a possible delisting from the Nasdaq. But its CEO, a former top official at Genzyme, remains confident that the company will avoid that fate. Biostage (Nasdaq: BSTG) said Monday it had received a letter from the exchange stating that it failed to meet two minimum requirements for listing: a $1 share price and $2.5 million in stockholders' equity. The 25-employee company said… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Holliston biotech faces possible delisting, but CEO remains confident
Biostage, a Holliston-based biotech developing organ implants to treat cancers in the respiratory tract, said Monday it faces a possible delisting from the Nasdaq. But its CEO, a former top official at Genzyme, remains confident that the company will avoid that fate. Biostage (Nasdaq: BSTG) said Monday it had received a letter from the exchange stating that it failed to meet two minimum requirements for listing: a $1 share price and $2.5 million in stockholders' equity. The 25-employee company said… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 22, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Triple-combo inhaler for COPD wins recommendation for approval in EU
Chiesi Group said today that the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended that the EMA approve its extra-fine triple combination inhaler for the treatment of chronic obstructive pulmonary disease. The Trimbow device combines an inhaled corticosteroid, a long-acting beta2-agonist and a long-acting muscarinic antagonist. The healthcare group said it is the 1st time the extra-fine triple therapy has been available in a single inhaler. Get the full story at our sister site, Drug Delivery Business News. The post Triple-combo inhaler for COPD wins recommendation for approval in...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat chiesigroup Source Type: news

Philips, ResMed tout collaborative home ventilation therapy COPD study results
This study shows that home non-invasive ventilation is a potent, therapeutic tool that clinicians can use to help keep patients with advanced COPD out of the hospital. We hope that this will, in turn, allow them to lead healthier and more active lives at home. These findings add considerably to our knowledge of this highly prevalent and debilitating respiratory disorder, and are expected to greatly influence how clinicians care for patients with COPD on long-term oxygen therapy,” Philips chief medical liaison Dr. Teofilo Lee-Chiong Jr. said in a press release. “This trial adds decisively to the growin...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory ResMed Inc. royal-philips Source Type: news

KIT Inhibition by Imatinib Helps Severe Refractory Asthma
Improvement in airway hyperresponsiveness seen with imatinib versus placebo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Nine of Ten Practices Surveyed Have Dismissed Patients
Reasons include inappropriate behavior toward staff, violation of Rx policies, repeatedly missed appointments (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Allergy, Nephrology, Neurology, Nursing, Ophthalmology, Orthopedics, ENT, Psychiatry, Pulmonology, Rheumatology, Urology, Anesthesiology Source Type: news

Patients Often Prescribed Futile Drugs in Last Months of Life
Researchers find many still prescribed long - term disease - preventing medications (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 22, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Nephrology, Neurology, Nursing, Oncology, Pharmacy, Pulmonology, AIDS, Anesthesiology & Pain, Journal, Source Type: news